Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123779) titled 'Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: 35Pharma Inc
Condition:
Pulmonary Hypertension
Heart Failure With Preserved Ejection Fraction
Intervention:
Biological: HS235
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2025
Target Sample Size: 40
To...